← Back to headlines
ALX Oncology Reports GAAP EPS of -$0.13
ALX Oncology announced its GAAP Earnings Per Share (EPS) for the latest period, reporting a loss of $0.13 per share.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
